Nathan Leisenring

Nathan Leisenring

Nathan Leisenring

Third Year Resident

Start Year

2021

What are your career interests?

General Dermatology, Procedural Dermatology, Medical Education.

Why did you choose Duke for residency training?

As a medical student at Duke, I was lucky to spend significant time working with the Duke dermatology faculty and residents. I was impressed by Duke’s welcoming, inclusive culture and emphasis on resident and student education. I was additionally drawn to Duke’s diverse patient population and the ample opportunities for mentorship and research within the department.  

Education & Training

Undergraduate:  University of Pennsylvania, BA, Biology, 2015

Medical School: Duke University School of Medicine, MD, 2020

Internship: Internal Medicine, Lankenau Medical Center, Wynnewood, PA, 2020-2021

Residency: Dermatology, Duke University, 2021-2024

Awards & Honors

Publications & Presentations

  • Byrne KT, Leisenring NH, Bajor DL, Vonderheide RH. CSF-1R−dependent lethal hepatotoxicity when agonistic CD40 antibody is given before but not after chemotherapy. Journal of Immunology, 2016, 197: 179–187.
  • Leisenring NH, Floyd RW, Kirsch DG. Identifying novel mechanisms of p53-mediated tumor suppression. Oral Presentation at: 2019 American Association for Cancer Research Annual Meeting; 2019 April 2; Atlanta, GA.
  • Chen M, Xu ES, Leisenring NH, Cardona DM, Luo L, Ma Y, Ventura A, Kirsch DG. The fusion oncogene FUS-CHOP drives sarcomagenesis of high grade spindle cell sarcomas in mice. Sarcoma, 2019 Jul 25, 2019:1340261.
  • Chen M, Foster JP, Lock IC, Leisenring NH, Daniel AR, Floyd W, Xu ES, Davis IJ, Kirsch DG. Disruption of oncogenic targeting by ISWI via phosphorylation of a prion-like domain. bioRxiv March 12, 2020.
  • Leisenring NH, Rogers J, Telloni S, Mansoori P, Al-Rohil R, Marano A. Successful treatment of painful cutaneous vasculopathy with rivaroxaban in a patient with systemic lupus erythematosus. Journal of Drugs in Dermatology, 2020 May 1;19(5):544-546.
  • Eldik H, Leisenring NH, Al-Rohil R, Marano A. Cutaneous collagenous vasculopathy in a middle-aged woman with a history of prothrombin G20210A thrombophilia. Journal of Cutaneous Pathology. 2021 Jan 20; published online ahead of print.